Transfer of Stablelab to Zoetis Inc.
Pegasus Capital has advised Epona Biotech Ltd. on the transfer of its Stablelab diagnostic blood test to Zoetis Inc., the world’s leading animal health company. Stablelab is a hand-held, point-of-care, diagnostic blood test, which detects and quantifies the biomarker Serum Amyloid A, a major acute phase protein produced by the liver. By measuring Serum Amyloid A, Stablelab provides veterinarians with critical information relating to equine inflammation in as little as 10 minutes. Zoetis Inc. will manufacture, market and distribute Stablelab, thereby immediately giving the test significantly increased global coverage in the equine health market.
Terms: Not disclosed